Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 65 results
Sort by: relevance publication year
Showing results for ISSN matching 2456-3927

Multiple Sclerosis: Promising New Treatment - A Clinical Review

JOURNAL ARTICLE published 30 December 2016 in NeuroPharmac Journal

Authors: Abdulrahman Alshahrani

https://doi.org/10.37881/1.110 Actions

Moderation in Asbab-e-Sitta Zarooriya (Six essential factors): A Unique Practice for Boosting Immunity

JOURNAL ARTICLE published 30 August 2022 in NeuroPharmac Journal

Authors: Naeem Khan | Rizwan Mansoor Khan | Abdul Aziz Khan

https://doi.org/10.37881/1.714 Actions

JOURNAL ISSUE published 25 August 2019 in NeuroPharmac Journal

https://doi.org/10.37881/1.4 Actions

Protective effect of Majoon Muṣaffī-i-Khūn (MMK) in cyclophosphamide-induced thrombocytopenia in male Sprague Dawley rats

JOURNAL ARTICLE published 30 August 2021 in NeuroPharmac Journal

Authors: Rukhsar Basheer | Nasreen Jahan | Jamil Ahmad

https://doi.org/10.37881/1.619 Actions

JOURNAL ISSUE published 25 April 2017 in NeuroPharmac Journal

https://doi.org/10.37881/1.21 Actions

Cannabidiol: FDA approved new drug for the Lennox-Gastaut syndrome and Dravet Syndrome: Pharmacotherapeutics review

JOURNAL ARTICLE published 25 April 2019 in NeuroPharmac Journal

Authors: Aslam Pathan | College of Medicine, Shaqra University, Shaqra, Saudi Arabia

https://doi.org/10.37881/1.413 Actions

The methods of biofuel generation by using microalgae: A review

JOURNAL ARTICLE published 30 April 2022 in NeuroPharmac Journal

Authors: Hanoof Alkhodairy

https://doi.org/10.37881/1.710 Actions

Role of Dipstick (Leucocyte Esterase Reagent Strips) in the Rapid Bedside Diagnosis of Spontaneous Bacterial Peritonitis

JOURNAL ARTICLE published 30 April 2022 in NeuroPharmac Journal

Authors: Sumairaa Ashai | Suhail Ashraf | Mohit Srivastava

https://doi.org/10.37881/1.713 Actions

Alzheimer’s Disease: Pharmacotherapy of subjective cognitive decline

JOURNAL ARTICLE published 30 August 2018 in NeuroPharmac Journal

Authors: Aslam Pathan | Abdulrahman Alshahrani

https://doi.org/10.37881/1.321 Actions

Gold Standard of Symptomatic treatment in Parkinson disease: Carbidopa / Levodopa

JOURNAL ARTICLE published 30 December 2018 in NeuroPharmac Journal

Authors: Aslam Pathan | Abdulrahman Alshahrani

https://doi.org/10.37881/1.331 Actions

Potential use of neuroprotective and L-DOPA-rich plants in parkinsonian therapy

JOURNAL ARTICLE published 30 December 2023 in NeuroPharmac Journal

Authors: Jamal Arif | Yusuf Jamal | Feras Almarshad | Abdulrahman Alshahrani | Mohammed Atef

https://doi.org/10.37881/1.831 Actions

Caplacizumab: First FDA-approved therapy in 2019 for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura

JOURNAL ARTICLE published 25 April 2019 in NeuroPharmac Journal

Authors: Feras Almarshad | College of Medicine, Shaqra University, Shaqra, Saudi Arabia

https://doi.org/10.37881/1.414 Actions

The anticancer mechanism of human antimicrobial peptide LL-37

JOURNAL ARTICLE published 30 December 2021 in NeuroPharmac Journal

Authors: Aqeel Ahmad | Mohammed Ali Mullah Fawaz

https://doi.org/10.37881/1.635 Actions

Stiripentol: New approved drug for the Dravet syndrome: Pharmacotherapeutics review

JOURNAL ARTICLE published 25 April 2019 in NeuroPharmac Journal

Authors: Aslam Pathan | College of Medicine, Shaqra University, Shaqra, Saudi Arabia

https://doi.org/10.37881/1.415 Actions

Therapeutic applications of mesenchymal cells derived from human placenta: A comprehensive meta-review

JOURNAL ARTICLE published 30 December 2021 in NeuroPharmac Journal

Authors: Smita Rastogi Verma | Saanya Yadav | Ritika Luthra

https://doi.org/10.37881/1.637 Actions

Peganum harmala seeds: evaluation of antiasthmatic effect by using clonidine induced mast cell degranulation

JOURNAL ARTICLE published 30 December 2016 in NeuroPharmac Journal

Authors: Aslam Pathan

https://doi.org/10.37881/1.114 Actions

FDA-approves the first therapy in 2018 for the seizures associated with Dravet syndrome

JOURNAL ARTICLE published 25 April 2019 in NeuroPharmac Journal

Authors: Aslam Pathan | College of Medicine, Shaqra University, Shaqra, Saudi Arabia | Abdulrahman Alshahrani

https://doi.org/10.37881/1.412 Actions

Identification of biomolecules for Alzheimer's disease using docking analysis of tau protein

JOURNAL ARTICLE published 30 August 2021 in NeuroPharmac Journal

Authors: Mansi Agrahari | Kanu Megha | Kajal Dahiya | Ila Sharma | Ankur Sharma | Niraj Kumar Jha | Vineet Kumar Goswami | Riya Raj | Kavindra Kumar Kesari | Saurabh Kumar Jha

https://doi.org/10.37881/1.617 Actions

Multiple Sclerosis: Promising New Treatment - A Clinical Review

JOURNAL ARTICLE published 25 December 2016 in NeuroPharmac Journal

Authors: Abdulrahman Alshahrani | College of Medicine, Shaqra | Shaqra University, Saudi Arabia

https://doi.org/10.37881/1.111 Actions

COVID-19 in the Shaqra, Saudi Arabia: prevalence and prevention strategies

JOURNAL ARTICLE published 30 December 2020 in NeuroPharmac Journal

Authors: Aslam Pathan | Abdulrahman Alshahrani | Feras Almarshad

https://doi.org/10.37881/1.531 Actions
Feedback: support@crossref.org